Search research articles
Contact Us
Filters
Showing results (141-150 of 206) with videos related to
Page
of 21
Sort By:
The Journal of Urology
|
May 25, 2021
Pathological Downstaging and Survival Outcomes Associated with Neoadjuvant Chemotherapy for Variant Histology Muscle Invasive Bladder Cancer
Nicholas H Chakiryan, Da David Jiang, Kyle A Gillis, et al.
BJU International
|
November 1, 2024
A luminal non-coding RNA-based genomic classifier confirms favourable outcomes in patients with clinically organ-confined bladder cancer treated with radical cystectomy
Joep J de Jong, James A Proudfoot, Siamak Daneshmand, et al.
European Urology Open Science
|
February 12, 2025
Molecular Subtyping for Predicting Pathological Upstaging and Survival Outcomes in Clinically Organ-confined Bladder Cancer Patients Undergoing Radical Cystectomy
Joep J de Jong, James A Proudfoot, Siamak Daneshmand, et al.
European Urology
|
October 1, 2024
FGFR Inhibition in Urothelial Carcinoma
Roger Li, Joshua Linscott, James W F Catto, et al.
Urology
|
August 23, 2025
Smoking is Associated with Poorer Survival Outcomes Following Nephroureterectomy for Upper Tract Urothelial Cancer
Kelly Lehner, Roger Li, Patrick J Hensley, et al.
The Oncologist
|
March 23, 2026
Homologous Recombination Deficiency and Genomic Alterations in Advanced Prostate Cancer: Insights for Precision Therapy
Chiara Mercinelli, Dean Pavlick, Neeraj Agarwal, et al.
The Journal of Urology
|
September 25, 2019
The Role of Fluorescence In Situ Hybridization for Predicting Recurrence after Adjuvant bacillus Calmette-Guérin in Patients with Intermediate and High Risk Nonmuscle Invasive Bladder Cancer: A Systematic Review and Meta-Analysis of Individual Patient Data
Esmée I M L Liem, Jorg R Oddens, Robin W M Vernooij, et al.
Current Oncology Reports
|
June 5, 2024
From Detection to Cure - Emerging Roles for Urinary Tumor DNA (utDNA) in Bladder Cancer
Joshua A Linscott, Hiroko Miyagi, Prithvi B Murthy, et al.
Breast Cancer Research and Treatment
|
January 11, 2015
Mutation screening of PALB2 in clinically ascertained families from the Breast Cancer Family Registry
Tú Nguyen-Dumont, Fleur Hammet, Maryam Mahmoodi, et al.
Clinical and Translational Medicine
|
March 10, 2026
Multi-omic profiling defines three distinct molecular subtypes of urothelial carcinoma with implications for precision therapy
Nils C H van Creij, Piotr Tymoszuk, Florian Handle, et al.
Page
of 21
Search research articles
Search
Showing results (141-150 of 206) with videos related to
Sort By:
Page
of 21
The Journal of Urology
|
May 25, 2021
Pathological Downstaging and Survival Outcomes Associated with Neoadjuvant Chemotherapy for Variant Histology Muscle Invasive Bladder Cancer
Nicholas H Chakiryan, Da David Jiang, Kyle A Gillis, et al.
BJU International
|
November 1, 2024
A luminal non-coding RNA-based genomic classifier confirms favourable outcomes in patients with clinically organ-confined bladder cancer treated with radical cystectomy
Joep J de Jong, James A Proudfoot, Siamak Daneshmand, et al.
European Urology Open Science
|
February 12, 2025
Molecular Subtyping for Predicting Pathological Upstaging and Survival Outcomes in Clinically Organ-confined Bladder Cancer Patients Undergoing Radical Cystectomy
Joep J de Jong, James A Proudfoot, Siamak Daneshmand, et al.
European Urology
|
October 1, 2024
FGFR Inhibition in Urothelial Carcinoma
Roger Li, Joshua Linscott, James W F Catto, et al.
Urology
|
August 23, 2025
Smoking is Associated with Poorer Survival Outcomes Following Nephroureterectomy for Upper Tract Urothelial Cancer
Kelly Lehner, Roger Li, Patrick J Hensley, et al.
The Oncologist
|
March 23, 2026
Homologous Recombination Deficiency and Genomic Alterations in Advanced Prostate Cancer: Insights for Precision Therapy
Chiara Mercinelli, Dean Pavlick, Neeraj Agarwal, et al.
The Journal of Urology
|
September 25, 2019
The Role of Fluorescence In Situ Hybridization for Predicting Recurrence after Adjuvant bacillus Calmette-Guérin in Patients with Intermediate and High Risk Nonmuscle Invasive Bladder Cancer: A Systematic Review and Meta-Analysis of Individual Patient Data
Esmée I M L Liem, Jorg R Oddens, Robin W M Vernooij, et al.
Current Oncology Reports
|
June 5, 2024
From Detection to Cure - Emerging Roles for Urinary Tumor DNA (utDNA) in Bladder Cancer
Joshua A Linscott, Hiroko Miyagi, Prithvi B Murthy, et al.
Breast Cancer Research and Treatment
|
January 11, 2015
Mutation screening of PALB2 in clinically ascertained families from the Breast Cancer Family Registry
Tú Nguyen-Dumont, Fleur Hammet, Maryam Mahmoodi, et al.
Clinical and Translational Medicine
|
March 10, 2026
Multi-omic profiling defines three distinct molecular subtypes of urothelial carcinoma with implications for precision therapy
Nils C H van Creij, Piotr Tymoszuk, Florian Handle, et al.
Page
of 21